Cocrystal Pharma, Inc.
COMBINATION THERAPY FOR TREATMENT OF HCV
Last updated:
Abstract:
Disclosed herein are combination therapies for use in the treatment or prevention of HCV by administering Compound A and a second HCV inhibitor.
Status:
Application
Type:
Utility
Filling date:
9 May 2019
Issue date:
3 Jun 2021